Valuation: West Pharmaceutical Services, Inc.

Market Cap 2.87TCr 16TCr 2.57TCr 2.37TCr 2.15TCr 4.01TCr 2,72900Cr 4.09TCr 28TCr 11TCr 1,43600Cr 11TCr 11TCr 4,52800Cr P/E 2026 *
48.1x
P/E 2027 * 40.2x
Enterprise Value 2.81TCr 15TCr 2.52TCr 2.32TCr 2.1TCr 3.93TCr 2,67100Cr 4TCr 28TCr 11TCr 1,40500Cr 11TCr 10TCr 4,43200Cr EV / Sales 2026 *
8.23x
EV / Sales 2027 * 7.7x
Free-Float
91.94%
Yield 2026 *
0.23%
Yield 2027 * 0.24%
1 day-2.36%
3 months-3.90%
6 months+14.00%
Current year+20.83%
Current year 34.5
Extreme 34.5
53.25
1 year 34.5
Extreme 34.5
53.25
3 years 32.64
Extreme 32.64
60
5 years 30.7
Extreme 30.7
75.51
10 years 30.7
Extreme 30.7
75.51
Manager TitleAgeSince
Chief Executive Officer 52 31/08/2026
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-.--% - - 2.87TCr
+1.56%+2.41%-14.82%+14.19% 18TCr
-6.38%-4.98%-20.90%+11.15% 11TCr
-0.59%+1.18%+6.12%+37.97% 12TCr
+3.42%+1.71%-42.32%+9.52% 9.46TCr
+0.09%-0.05%-3.04%+78.44% 6.31TCr
-0.46%+0.42%+8.19%+82.97% 5.57TCr
-0.23%-0.52%+10.31%-21.19% 5.39TCr
-4.30%-1.64%-12.30%+39.06% 4.34TCr
+0.58%+2.00%-1.07%-6.43% 3.47TCr
Average -0.87%+0.06%-7.76%+27.30% 8.44TCr
Weighted average by Cap. -0.56%+0.23%-10.66%+25.22%

Financials

2026 *2027 *
Net sales 341.82Cr 1.86TCr 306.13Cr 281.59Cr 255.15Cr 476.93Cr 32TCr 485.86Cr 3.36TCr 1.35TCr 17TCr 1.28TCr 1.26TCr 54TCr 361.65Cr 1.96TCr 323.9Cr 297.93Cr 269.95Cr 504.61Cr 34TCr 514.05Cr 3.55TCr 1.43TCr 18TCr 1.36TCr 1.33TCr 57TCr
Net income 66Cr 357.81Cr 59Cr 54Cr 49Cr 92Cr 6.26TCr 94Cr 647.34Cr 259.86Cr 3.29TCr 247.29Cr 242.03Cr 10TCr 72Cr 392.27Cr 65Cr 60Cr 54Cr 100.79Cr 6.86TCr 102.68Cr 709.68Cr 284.89Cr 3.61TCr 271.11Cr 265.34Cr 11TCr
Net Debt -61Cr -330.86Cr -55Cr -50Cr -45Cr -85Cr -5.79TCr -87Cr -598.57Cr -240.29Cr -3.04TCr -228.66Cr -223.8Cr -9.6TCr -91Cr -493.68Cr -81Cr -75Cr -68Cr -126.85Cr -8.63TCr -129.22Cr -893.14Cr -358.54Cr -4.54TCr -341.19Cr -333.93Cr -14TCr
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
412.62USD
Average target price
445.33USD
Spread / Average Target
+7.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - West Pharmaceutical Services, Inc.